Sarcomatoid Renal Cell Carcinoma: A Comprehensive Review of the Biology and Current Treatment Strategies
Open Access
- 1 January 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 17 (1), 46-54
- https://doi.org/10.1634/theoncologist.2011-0227
Abstract
Learning Objectives: After completing this course, the reader will be able to: Describe histologic features associated with sarcomatoid renal cell carcinoma.Outline current surgical approaches to treating sarcomatoid renal cell carcinoma. This article is available for continuing medical education credit at CME.TheOncologist.com Recent advancements in the molecular characterization of renal cell carcinoma altered the classification system and now kidney cancer is divided into several distinct histologic subtypes. Although once a separate histologic category, sarcomatoid renal cell carcinoma is no longer considered a separate tumor type because it can occur with all histologic subtypes. Limited research on tumors with sarcomatoid change has led to minimal progress in the understanding and treatment of these tumors. Because the sarcomatoid variant of renal cell carcinoma can account for approximately one in six cases of advanced kidney cancer, we hope to familiarize clinicians with these tumors by describing the historic background, histologic features, molecular characterization, diagnosis, prognosis, treatment strategies, and active clinical trials of this aggressive type of tumor.Keywords
Funding Information
- Intramural Research Program of the NIH
- National Cancer Institute
- Center for Cancer Research
This publication has 66 references indexed in Scilit:
- Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinomaBJU International, 2012
- Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomyBJU International, 2010
- Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapyCancer, 2009
- Cytoreductive Nephrectomy for Kidney Cancer With Sarcomatoid Histology—Is Up-Front Resection Indicated and, if Not, is it Avoidable?Journal of Urology, 2009
- Performance status and cytoreductive nephrectomyCancer, 2008
- Immunohistochemical Expression of Hypoxia Inducible Factor-1α and its Downstream Molecules in Sarcomatoid Renal Cell CarcinomaJournal of Urology, 2007
- Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Is It Still Imperative in the Era of Targeted Therapy?Clinical Cancer Research, 2007
- Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinomaCancer, 2003
- Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North AmericaAmerican Journal of Human Genetics, 2003
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993